|
1
|
Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM.
|
PLoS One
|
2008
|
3.68
|
|
2
|
Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma.
|
Cell Cycle
|
2009
|
1.50
|
|
3
|
Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma.
|
J Clin Oncol
|
2003
|
1.47
|
|
4
|
Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma.
|
Cancer Res
|
2002
|
1.36
|
|
5
|
Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma.
|
Cancer
|
2005
|
1.16
|
|
6
|
c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571.
|
Int J Cancer
|
2003
|
0.94
|
|
7
|
Expression of the lipogenic enzyme fatty acid synthase (FAS) in retinoblastoma and its correlation with tumor aggressiveness.
|
Invest Ophthalmol Vis Sci
|
2003
|
0.93
|
|
8
|
Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcoma.
|
Clin Cancer Res
|
2008
|
0.92
|
|
9
|
Nephroblastoma: multidrug-resistance P-glycoprotein expression in tumor cells and intratumoral capillary endothelial cells.
|
Am J Clin Pathol
|
2002
|
0.91
|
|
10
|
A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience.
|
J Neurooncol
|
2008
|
0.91
|
|
11
|
Prognostic factors in pleuro-pulmonary blastoma.
|
Pediatr Blood Cancer
|
2007
|
0.89
|
|
12
|
Complete second look operation and radiotherapy in locally advanced non-alveolar rhabdomyosarcoma in children: A report from the AIEOP soft tissue sarcoma committee.
|
Pediatr Blood Cancer
|
2008
|
0.88
|
|
13
|
High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience.
|
Cancer
|
2006
|
0.87
|
|
14
|
Pulmonary blastomas of childhood: histologic, immunohistochemical, ultrastructural aspects and therapeutic considerations.
|
Ultrastruct Pathol
|
2005
|
0.86
|
|
15
|
Improved survival for children with parameningeal rhabdomyosarcoma: results from the AIEOP soft tissue sarcoma committee.
|
Pediatr Blood Cancer
|
2008
|
0.84
|
|
16
|
Hemangioendothelioma: successful therapy with interferon-alpha: a study in Association with the Italian Pediatric Haematology/Oncology Society (AIEOP).
|
Med Pediatr Oncol
|
2002
|
0.84
|
|
17
|
Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases.
|
Virchows Arch
|
2003
|
0.83
|
|
18
|
Expression of the lipogenic enzyme fatty acid synthase (FAS) as a predictor of poor outcome in nephroblastoma: an interinstitutional study.
|
Med Pediatr Oncol
|
2003
|
0.81
|
|
19
|
Different pattern of matrix metalloproteinases expression in alveolar versus embryonal rhabdomyosarcoma.
|
J Pediatr Surg
|
2004
|
0.80
|
|
20
|
Rhabdomyosarcoma associated hypertrophic osteoarthropathy in a child: detection by bone scintigraphy.
|
Clin Nucl Med
|
2009
|
0.78
|
|
21
|
Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma.
|
Eur J Cancer
|
2010
|
0.77
|
|
22
|
Acquired amnesia in childhood: a single case study.
|
Neuropsychologia
|
2006
|
0.76
|
|
23
|
Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors.
|
Clin Cancer Res
|
2005
|
0.76
|
|
24
|
Detection and clinical significance of disseminated tumour cells at diagnosis in bone marrow of children with localised rhabdomyosarcoma.
|
Eur J Cancer
|
2005
|
0.76
|
|
25
|
Antibiotic lock with vancomycin and urokinase can successfully treat colonized central venous catheters in pediatric cancer patients.
|
Pediatr Infect Dis J
|
2004
|
0.75
|
|
26
|
Tumor lysis syndrome and neuroblastoma.
|
Med Pediatr Oncol
|
2003
|
0.75
|
|
27
|
Pancreatitis as an unusual presentation of rhabdomyosarcoma.
|
Pediatr Blood Cancer
|
2009
|
0.75
|
|
28
|
Nephroblastoma. DNA characteristics and their modifications induced by prenephrectomy chemotherapy: a cytofluorimetric study.
|
Pediatr Pathol Mol Med
|
2002
|
0.75
|
|
29
|
Immunomagnetic selection of progenitor cells from peripheral blood after thawing with an automatic system in a pediatric patient with a neuroblastoma.
|
Transfusion
|
2007
|
0.75
|
|
30
|
Expression of glial cell line-derived neurotrophic factor and neurturin in mature kidney, nephrogenic rests, and nephroblastoma: possible role as differentiating factors.
|
Pediatr Dev Pathol
|
2004
|
0.75
|
|
31
|
Continuing response to subsequent treatment lines with tyrosine kinase inhibitors in an adolescent with metastatic renal cell carcinoma.
|
J Pediatr Hematol Oncol
|
2011
|
0.75
|
|
32
|
Epithelioid osteosarcoma of the jaw.
|
Pediatr Blood Cancer
|
2009
|
0.75
|